{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-176987","form_type":"8-K","ticker":"ORIC","cik":"0001796280","company_name":"Oric Pharmaceuticals, Inc.","filed_at":"2022-06-21T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.351522+00:00","generated_at":"2026-06-25T00:31:10.423417+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"ORIC shareholders elect two Class II directors and ratify KPMG as auditor","bullets":["Steven L. Hoerter and Angie You, Ph.D. elected as Class II directors until 2025 annual meeting.","Hoerter received 30,420,083 for, 21,252 withheld, 3,427,848 broker non-votes.","Angie You received 30,420,703 for, 20,632 withheld, 3,427,848 broker non-votes.","KPMG LLP ratified as independent auditor for FY2022 with 33,863,053 for, 6,025 against, 105 abstain.","Meeting held June 17, 2022 with 85.87% of outstanding shares represented."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-176987","json":"https://secwatch.observer/filing/0001193125-22-176987.json","markdown":"https://secwatch.observer/filing/0001193125-22-176987.md","text":"https://secwatch.observer/filing/0001193125-22-176987.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1796280/000119312522176987/0001193125-22-176987-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1796280/000119312522176987/d708502d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:31:10.423417+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}